Insight

Some perspective on TRUST-II with talectrectinib

Photo taken from IASLC/X

Sep 15, 2024, 01:34

Some perspective on TRUST-II with talectrectinib

IASLC shared on X:

“ In this episode, Narjust Florez and Stephen V Liu, recap WCLC24.

Jacob Sands discusses TROPION-Lung01 with datopotamab, deruxtecan and DeLLphi-301 with tarlatamab.

Hidehito Horinouchi reports results from the LUMINOSITY study, and Noemi Reguart gives some perspective on TRUST-II with talectrectinib.

Listen Now.”

Source: IASLC/X

cancer datopotamab DeLLphi-301 Deruxtecan Hidehito Horinouchi IASLC Jacob Sands LUMINOSITY study Narjust Florez Noemi Reguar OncoDaily Oncology Stephen V Liu talectrectinib Tarlatamab TROPION-Lung01 WCLC24

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Dec 21, 2024, 10:19

A Portrait of Germline Pathogenic Variants in Breast Cancer Genes in Brazil

Dialogues

Dec 21, 2024, 10:09

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Blog

Dec 21, 2024, 09:22

When the world of science and sports comes together! - The V Foundation

Blog

Dec 21, 2024, 09:16

Timely cancer treatment isn’t just a goal, It’s a necessity - European Cancer Organisation

Science

Dec 21, 2024, 09:06

Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial

Blog

Dec 21, 2024, 09:00

Miriam Mutebi: Does Nipple and Areola Size Matter?

Science

Dec 21, 2024, 08:51

Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis

Science

Dec 21, 2024, 08:48

Oncology Brothers: Another ALK inhibitor gets FDA approval

Science

Dec 21, 2024, 08:42

Eric K. Singhi: Decoding clinical trial jargon

Science

Dec 21, 2024, 08:37

Gustavo Viani: The Role of Radiotherapy on the management of HCC

Science

Dec 21, 2024, 08:29

Bishal Gyawali: The case of cancer drug Xtandi

Blog

Dec 21, 2024, 08:18

Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers?